Pregled po CROSBI profilu: Vilma Dembitz (CROSBI Profil: 32110, MBZ: 341295)
Pronađeno 18 radova
-
1.Dembitz, Vilma; Lalic, Hrvoje; Kodvanj, Ivan; Tomic, Barbara; Batinic, Josip; Dubravcic, Klara; Batinic, Drago; Bedalov, Antonio; Visnjic, Dora5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts // Bmc cancer, 20 (2020), 1; 1090, 12 doi:10.1186/s12885-020-07533-6 (međunarodna recenzija, članak, ostalo)
-
2.Dembitz, Vilma; Tomić, Barbara; Kodvanj, Ivan; Simon, Julian; Bedalov, Antonio; Visnjic, DoraThe ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 kinase via pyrimidine depletion // The Journal of biological chemistry, 294 (2019), 42; 15257-15270 (međunarodna recenzija, članak, znanstveni)
-
3.Višnjić, Dora; Dembitz, Vilma; Lalić, HrvojeThe Role of AMPK/mTOR Modulators in the Therapy of Acute Myeloid Leukemia // Current medicinal chemistry, 25 (2018), 1-20 (međunarodna recenzija, članak, znanstveni)
-
4.Dembitz, Vilma; Lalić, Hrvoje; Višnjić, Dora.5-Aminoimidazole-4-carboxamide ribonucleoside- induced autophagy flux during differentiation of monocytic leukemia cells // Cell Death Discovery, 3 (2017), 17066, 12 doi:10.1038/cddiscovery.2017.66. (međunarodna recenzija, članak, znanstveni)
-
5.Rozovski, Uri; Verstovšek, Srđan; Manshouri, Taghi; Dembitz, Vilma; Božinović, Ksenija; Newberry, Kate; Zhang, Ying; Bove, Joseph E.; Pierce, Sherry; Kantarjian, Hagop; Estrov, ZeevAn accurate, simple prognostic model consisting of age, JAK2, CALR, and MPL mutation status for patients with primary myelofibrosis // Haematologica, 102 (2016), 1; 79-84 doi:10.3324/haematol.2016.149765 (podatak o recenziji nije dostupan, članak, znanstveni)
-
6.Banfić, Hrvoje; Crljen, Vladiana; Lukinović-Škudar, Vesna; Dembitz, Vilma; Lalić, Hrvoje; Bedalov, Antonio; Višnjić, DoraInositol pyrophosphates modulate cell cycle independently of alteration in telomere length // Advances in Biological Regulation, 60 (2016), 22-28 (međunarodna recenzija, članak, znanstveni)
-
7.Dembitz, Vilma; Lalić, Hrvoje; Ostojić, Alen; Vrhovac, Radovan; Banfić, Hrvoje; Višnjić, DoraThe mechanism of synergistic effects of arsenic trioxide and rapamycin in acute myeloid leukemia cell lines lacking typical t(15 ; 17) translocation // International journal of hematology, 102 (2015), 1; 12-24 doi:10.1007/s12185-015-1776-2 (međunarodna recenzija, članak, znanstveni)
-
8.Višnjić, Dora; Lalić, Hrvoje; Dembitz, Vilma; Banfić, HrvojeMetabolism and differentiation // Periodicum biologorum, 116 (2014), 1; 37-43 (domaća recenzija, pregledni rad, ostalo)
-
9.Manshouri, Taghi; Estrov, Zeev; Knez, Liza; Zhang, Ying; Bozinovic, Ksenija; Dembitz, Vilma; Kantarjian, Hagop M; Verstovsek, SrdanBONE Marrow Stromal CELL Paracrine Factors from PMF Patients, but NOT Healthy Donors, Protect JAK2V617F CELLS from Ruxotinib-Induced Apoptosis // Blood
San Francisco, California, SAD, 2014. str. 1872-1872 (poster, međunarodna recenzija, sažetak, znanstveni) -
10.Rozovski, Uri; Manshouri, Taghi; Dembitz, Vilma; Bozinovic, Ksenija; Pierce, Sherry; Kantarjian, Hagop M; Estrov, Zeev; Verstovsek, SrdanJAK2, Calr and MPL Mutation Status Predicts the Survival Outcome of Patients with Primary Myelofibrosis // Blood
San Francisco, California, SAD, 2014. str. 1829-1829 (poster, međunarodna recenzija, sažetak, znanstveni) -
11.Rozovski, Uri; Manshouri, Taghi; Dembitz, Vilma; Bozinovic, Ksenija; Pierce, Sherry; Kantarjian, Hagop; Estrov, Zeev; Verstovsek, SrdanPrognostic model based on JAK2, CALR and MPL mutation status and age predicts the survival outcome of patients with primary myelofibrosis // Society of Hematologic Oncology, SOHO Annual Meeting Proceedings Vol 2, No. 1
Houston, 2014. str. 702-702 (poster, međunarodna recenzija, sažetak, znanstveni) -
12.Višnjić, Dora; Lalić, Hrvoje; Dembitz, Vilma; Banfić, HrvojeMetabolism and differentiation // Periodicum biologorum, 116 (2014), 1; 37-43 (međunarodna recenzija, pregledni rad, znanstveni)
-
13.Lalić, Hrvoje; Dembitz, Vilma; Lukinović-Škudar, Vesna; Banfić, Hrvoje; Višnjić, DoraAICAR induces differentiation of acute myeloid leukemia cells // Leukemia & lymphoma, 55 (2014), 10; 2375-2383 doi:10.3109/10428194.2013.876633 (međunarodna recenzija, članak, znanstveni)
-
14.Dembitz, Vilma; Lalić, Hrvoje; Ostojić, Alen; Vrhovac, Radovan; Višnjić, DoraArsenic trioxide and rapamycin in acute myeloid leukemia (AML): potential synergistic effects // Periodicum biologorum, Vol 115, Suppl 2, 2013. - 3. Congress of Croatian Physiological Society and 1. Regional Congress of the Physiological Societies / Vitale, Branko (ur.).
Zagreb, 2013. (poster, međunarodna recenzija, sažetak, znanstveni) -
15.Lalić, Hrvoje; Dembitz, Vilma; Lukinović-Škudar, Vesna; Banfić, Hrvoje; Višnjić, DoraAICAR induces differentiation of acute myeloid leukemia cells // Periodicum biologorum, Vol 115, Suppl 2, 2013. - 3.Congress of Croatian Physiological Society and 1.Regional Congress of the Physiological Societies / Vitale, Branko (ur.).
Zagreb, 2013. (poster, međunarodna recenzija, sažetak, znanstveni) -
16.Dembitz, VilmaRapamicin i sve-trans-retinska kiselina pojačavaju učinak arsenova trioksida na proliferaciju leukemijskijh stanica, 2012., diplomski rad, diplomski, Medicinski fakultet, Zagreb
-
17.Dembitz, Vilma; Lalić, Hrvoje; Ostojić, Alen; Šiftar, Zoran; Vrhovac, Radovan; Višnjić, DoraInhibicija kinaze mTOR pojačava djelovanje arsenova trioksida (ATO) na stanice akutne mijeloične leukemije (AML) // Liječnički vjesnik ; godište 134 ; (Supl. 2) / Anić, Branimir (ur.).
Zagreb, 2012. str. 164-165 (poster, domaća recenzija, sažetak, znanstveni) -
18.Miše, Joško; Dembitz, Vilma; Banfić, Hrvoje; Višnjić, DoraCombined Inhibition of PI3K and mTOR Exerts Synergistic Antiproliferative Effect, but Diminishes Differentiative Properties of Rapamycin in Acute Myeloid Leukemia Cells // Pathology oncology research, 17 (2011), 3; 645-656 doi:10.1007/s12253-011-9365-z (međunarodna recenzija, članak, znanstveni)
